Description
This induced pluripotent stem cell line was derived by using sendai viral vectors to reprogram a lymphoblastoid cell line generated from a female Central Core Disease of Muscle patient. HPIi008-A is described as having a normal karyotype and a heterozygous variant in the RYR1 gene. Expression of OCT4, NANOG, SOX2, CRIPTO, TRA-1-60 and SSEA-4 in undifferentiated cells, and directed differentiation to endoderm, mesoderm and ectoderm have been reported, although endoderm differentiation potential was reportedly significantly lower than observed in a control iPSC.
Tissue & Disease as reported
Genetic Information
Associated Publications
| Journal | Year | Article |
|---|---|---|
| Stem cell research | 2024 | Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene |
Line Custodianship
Cell Line Maintainer
Joshua Clayton
Affiliated Institutions
- Harry Perkins Institute of Medical Research, Nedlands, Australia
Cell Line Producer
Harry Perkins Institute of Medical Research
Affiliated Institutions
- Harry Perkins Institute of Medical Research, Nedlands, Australia